Corcept Therapeutics Market Cap

Corcept Therapeutics has a market cap or net worth of $3.58 billion as of March 9, 2026. Its market cap has decreased by -47.53% in one year.

Market Cap

3.58B

Enterprise Value

3.04B

1-Year Change

-47.53%

Ranking

#1589

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $3.58B, an increase of 1,164.46%. That is a compound annual growth rate of 12.28%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	3.60B	-1.57%
Dec 31, 2025	3.66B	-30.67%
Dec 31, 2024	5.28B	57.69%
Dec 29, 2023	3.35B	53.13%
Dec 30, 2022	2.19B	-4.35%
Dec 31, 2021	2.29B	-24.78%
Dec 31, 2020	3.04B	119.78%
Dec 31, 2019	1.38B	-10.36%
Dec 31, 2018	1.54B	-25.15%
Dec 29, 2017	2.06B	155.69%
Dec 30, 2016	806.10M	48.81%
Dec 31, 2015	541.70M	78.43%
Dec 31, 2014	303.60M	-5.24%
Dec 31, 2013	320.40M	124.53%
Dec 31, 2012	142.70M	-50.47%
Dec 30, 2011	288.10M	3.11%
Dec 31, 2010	279.40M	60.85%
Dec 31, 2009	173.70M	248.10%
Dec 31, 2008	49.90M	-59.17%
Dec 31, 2007	122.20M	336.43%
Dec 29, 2006	28.00M	-66.22%
Dec 30, 2005	82.90M	-41.54%
Dec 31, 2004	141.80M	-49.89%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Structure Therapeutics	4.09B
Ligand Pharmaceuticals	4.03B
Crinetics Pharmaceuticals	4.00B
Viking Therapeutics	3.81B
Centessa Pharmaceuticals	3.79B
ACADIA Pharmaceuticals	3.78B
ADMA Biologics	3.67B
Legend Biotech	3.50B

Market Cap Rankings